Global /South Korea /Healthcare /Drug Manufacturers - General /001630

Chong Kun Dang Holdings Corp.

001630

• KRX: 001630 • Delayed

49,350KRW -1%

31.95 USD

As of 26 June 2026, Chong Kun Dang Holdings Corp. has a market cap of $153.66M USD, ranking #22663 globally and #928 in South Korea. It ranks #2034 in the Healthcare sector, and #731 in the Drug Manufacturers - General industry.

Global Rank

22663

Country Rank

928

Sector Rank

2034

Industry Rank

731

Key Stats

Market Cap

$153.66MUSD

237.31B KRW

Enterprise Value

$606.75MUSD

937.05B KRW

Revenue (TTM)

$620.96MUSD

959.01B KRW

EBITDA (TTM)

$65.83MUSD

101.67B KRW

Net Income (TTM)

$26.18MUSD

40.43B KRW

EBITDA Margin

11%

Profit Margin

4.2%

PE Ratio

5.9

PS Ratio

0.2

PB Ratio

0.3

EV/EBITDA

9.2

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hee-Nam Choi open_in_new

Employees

Founded

1941

Website

ckd-holdings.com/company/summary.do open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	-2.2%	-0.3%	-0.3%	5.4%	7.5%	7.6%	-2%	-56%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	001630 (주)종근당홀딩스 ISIN: KR7001630003 Shares Out.: Shares Outstanding: 4.761M¹ Shares Float: 2.235M² TV: TradingView: KRX: 001630 SA: Stock Analysis: KRX: 001630 YF: Yahoo Finance: 001630.KS GF: Google Finance: KRX: 001630 BA: Barron's: 001630 MS: Morningstar: XKRX: 001630	49,350 KRW	TV: TradingView: KRX: 001630 SA: Stock Analysis: KRX: 001630 YF: Yahoo Finance: 001630.KS GF: Google Finance: KRX: 001630 BA: Barron's: 001630 MS: Morningstar: XKRX: 001630

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Chong Kun Dang Holdings Corp.

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.01B 13.91T KRW 6K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.67B 10.3T KRW 4K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.16B 7.97T KRW 3K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.89B 7.55T KRW 3K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.48B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.38B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 496K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 356K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 235K%	97.4	United States
Roche Holding AG SIX: RO	$316.45B 256.25B CHF 206K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.53B 215.59B GBP 185K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 178K%	15.1	United States

chevron_leftBack